The three phases of schizophrenia are the ... diagnosis until the condition is in the active phase. The final stage, residual schizophrenia, still causes symptoms, but not as many.

including those in the early stages of schizophrenia. Research has consistently shown that LAIs offer significant benefits for patients living with schizophrenia. Studies indicate that individuals ...

Newron Pharmaceuticals has clearance to press ahead with phase 3 development of its schizophrenia drug Evenamide after the FDA agreed a plan to address potential safety issues emerging from ...

CONNEX-1 (NCT04846868), CONNEX-2 (NCT04846881) and CONNEX-3 (NCT04860830 ... therapies in all stages of development and in different disease areas including schizophrenia and major depressive ...

There were signs in mid-stage studies ... also failed a phase 3 trial in 2020 but subsequently showed evidence that it may be able to target the negative symptoms of schizophrenia – such as ...